COVID-19 test kits

It seems that after an initial frenzy at the start of the COVID-19 pandemic, when seemingly almost any old test could somehow make it on the market (check out the April news review for comments on quality issues), we’ve seen not just quality tests but also kits with added features appear from summer 2020. More and more COVID-19 tests have been […]

Spiffin’ coronavirus vaccine

The purpose of a vaccine is effectively to train the immune system in recognising and combatting the virus quickly should there ever be a real infection. To do so, vaccines deliver virus components, which are harmless on their own, to the recipient’s immune system. These components are referred to as immunisation targets or immunogens. Once immune cells recognise and bind […]

Welcome to Bio-Babel

Working across disciplines can be confusing, not only due to professional jargon but also due to basic terminology being used interchangeably by different people or media sources. This is very true in the biomedical sphere. After a recent brief exchange with someone who is interested in technology applications in healthcare and life sciences, I was stimulated to propound some of […]

Supply chain innovation with blockchain

Optimising supply chain management provides several tremendous use cases for blockchain applications. Below is a quick summary of two very informative blockchain discussions on supply chain transformation that provide some useful overviews across different industries and various aspects to ponder. Here are some of my highlights. What is the minimum viable tracking unit? This may seem straightforward when looking at […]

Blue Steens in October 2020

Check out my latest monthly review! It showcases Blue Steens’ latest posts, some news from biopharma & medtech as well as interesting events I have attended or noticed. At a glance In terms of COVID-19, more interesting new test kits have emerged; remdesivir gained FDA approval, yet trial interpretations are still a mixed bag; and vaccine development remains a global […]

Quo vadis?

COVID-19 has had a huge impact on various industries including manufacturing, travel & tourism as well as life sciences and healthcare. When we talk about ‘industries’, inevitably we talk about human lives. Let’s look beyond the immediate turmoil into which many have been thrust. With the world around us changing at a seemingly accelerated speed, what’s out there to help […]

Blue Steens in Aug-Sep 2020

Check out my latest monthly review! It showcases Blue Steens’ latest posts, some news from biopharma & medtech as well as interesting events I have attended or noticed. At a glance In terms of COVID-19, test kits are becoming more elaborate; repurposed drugs promise to accelerate recovery; and vaccine development is in full swing globally with Russia having already approved […]

Plasma vs virus

Convalescent plasma (CP) therapy gained FDA emergency use authorisation (EUA) in August. It appears that this is surrounded by some controversy and suspicion of politicisation. Without getting anywhere near politics here, let’s not forget that health agencies’ interest in CP is nothing new. The FDA has previously encouraged survivors to donate plasma and supported developments in this space along with […]

Blue Steens in July 2020

Check out my latest monthly review! It showcases Blue Steens’ latest posts, some news from biopharma & medtech as well as interesting events I have attended or noticed. At a glance In terms of COVID-19, hydroxychloroquine as a potential treatment has fallen further from favour whilst remdesivir is in high demand; dexamethasone has also stood its ground; 4 highly promising […]